119 related articles for article (PubMed ID: 11850724)
1. Effective gene therapy for medullary thyroid carcinoma using recombinant adenovirus inducing tumor-specific expression of interleukin-12.
Yamazaki M; Zhang R; Straus FH; Messina M; Robinson BG; Hashizume K; DeGroot LJ
Gene Ther; 2002 Jan; 9(1):64-74. PubMed ID: 11850724
[TBL] [Abstract][Full Text] [Related]
2. Adenovirus-mediated tumor-specific combined gene therapy using Herpes simplex virus thymidine/ganciclovir system and murine interleukin-12 induces effective antitumor activity against medullary thyroid carcinoma.
Yamazaki M; Straus FH; Messina M; Robinson BG; Takeda T; Hashizume K; DeGroot LJ
Cancer Gene Ther; 2004 Jan; 11(1):8-15. PubMed ID: 14681722
[TBL] [Abstract][Full Text] [Related]
3. Genetic immunotherapy of established tumours with adenoviral vectors transducing murine interleukin-12 (mIL12) subunits in a rat medullary thyroid carcinoma model.
Zhang R; DeGroot LJ
Clin Endocrinol (Oxf); 2000 Jun; 52(6):687-94. PubMed ID: 10848872
[TBL] [Abstract][Full Text] [Related]
4. Eradication of murine bladder carcinoma by intratumor injection of a bicistronic adenoviral vector carrying cDNAs for the IL-12 heterodimer and its inhibition by the IL-12 p40 subunit homodimer.
Chen L; Chen D; Block E; O'Donnell M; Kufe DW; Clinton SK
J Immunol; 1997 Jul; 159(1):351-9. PubMed ID: 9200473
[TBL] [Abstract][Full Text] [Related]
5. Induction of antitumor immunity by direct intratumoral injection of a recombinant adenovirus vector expressing interleukin-12.
Gambotto A; Tüting T; McVey DL; Kovesdi I; Tahara H; Lotze MT; Robbins PD
Cancer Gene Ther; 1999; 6(1):45-53. PubMed ID: 10078963
[TBL] [Abstract][Full Text] [Related]
6. Thyroid cancer immuno-therapy with retroviral and adenoviral vectors expressing granulocyte macrophage colony stimulating factor and interleukin-12 in a rat model.
Tanaka K; Towata S; Nakao K; Mizuguchi H; Hayakawa T; Niwa M; Ishii N; Nagayama Y
Clin Endocrinol (Oxf); 2003 Dec; 59(6):734-42. PubMed ID: 14974915
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy for medullary thyroid carcinoma by a replication-defective adenovirus transducing murine interleukin-2.
Zhang R; Minemura K; De Groot LJ
Endocrinology; 1998 Feb; 139(2):601-8. PubMed ID: 9449631
[TBL] [Abstract][Full Text] [Related]
8. A tandemly repeated thyroglobulin core promoter has potential to enhance efficacy for tissue-specific gene therapy for thyroid carcinomas.
Takeda T; Yamazaki M; Minemura K; Imai Y; Inaba H; Suzuki S; Miyamoto T; Ichikawa K; Kakizawa T; Mori J; DeGroot LJ; Hashizume K
Cancer Gene Ther; 2002 Oct; 9(10):864-74. PubMed ID: 12224028
[TBL] [Abstract][Full Text] [Related]
9. Increased efficacy and safety in the treatment of experimental liver cancer with a novel adenovirus-alphavirus hybrid vector.
Guan M; Rodriguez-Madoz JR; Alzuguren P; Gomar C; Kramer MG; Kochanek S; Prieto J; Smerdou C; Qian C
Cancer Res; 2006 Feb; 66(3):1620-9. PubMed ID: 16452221
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxic effect of replication-competent adenoviral vectors carrying L-plastin promoter regulated E1A and cytosine deaminase genes in cancers of the breast, ovary and colon.
Akbulut H; Zhang L; Tang Y; Deisseroth A
Cancer Gene Ther; 2003 May; 10(5):388-95. PubMed ID: 12719708
[TBL] [Abstract][Full Text] [Related]
11. Gene-viral vectors: a promising way to target tumor cells and express anticancer genes simultaneously.
Qian Q; Sham J; Che X; Xu J; Xue H; Cui Z; Zhu B; Wu M
Chin Med J (Engl); 2002 Aug; 115(8):1213-7. PubMed ID: 12215295
[TBL] [Abstract][Full Text] [Related]
12. Gene therapy of a rat follicular thyroid carcinoma model with adenoviral vectors transducing murine interleukin-12.
Zhang R; DeGroot LJ
Endocrinology; 2003 Apr; 144(4):1393-8. PubMed ID: 12639922
[TBL] [Abstract][Full Text] [Related]
13. Gene therapy of established medullary thyroid carcinoma with herpes simplex viral thymidine kinase in a rat tumor model: relationship of bystander effect and antitumor efficacy.
Zhang R; DeGroot LJ
Thyroid; 2000 Apr; 10(4):313-9. PubMed ID: 10807059
[TBL] [Abstract][Full Text] [Related]
14. Specific tumor-cell killing with adenovirus vectors containing the apoptin gene.
Pietersen AM; van der Eb MM; Rademaker HJ; van den Wollenberg DJ; Rabelink MJ; Kuppen PJ; van Dierendonck JH; van Ormondt H; Masman D; van de Velde CJ; van der Eb AJ; Hoeben RC; Noteborn MH
Gene Ther; 1999 May; 6(5):882-92. PubMed ID: 10505114
[TBL] [Abstract][Full Text] [Related]
15. [Construction of a RU486 inducible recombinant adenoviral vector carrying murine interleukin-12 gene and experimental treatment of colonic carcinoma].
Chen J; Liu XS; Wang F; Xue XC; Fang GE; Su CQ; Qian QJ
Zhonghua Yi Xue Za Zhi; 2009 May; 89(20):1372-6. PubMed ID: 19671324
[TBL] [Abstract][Full Text] [Related]
16. Technology insight: gene therapy and its potential role in the treatment of medullary thyroid carcinoma.
Messina M; Robinson BG
Nat Clin Pract Endocrinol Metab; 2007 Mar; 3(3):290-301. PubMed ID: 17315037
[TBL] [Abstract][Full Text] [Related]
17. [Gene transfer of murine Flt3 ligand mediated by adenoviral vector efficiently induces growth inhibition of murine liver cancer].
Yang Q; Yang G; Wei L; Jia F; Wu M; Guo Y
Zhonghua Yi Xue Za Zhi; 2002 Jun; 82(11):775-9. PubMed ID: 12126551
[TBL] [Abstract][Full Text] [Related]
18. Gene therapy of orthotopic hepatocellular carcinoma in rats using adenovirus coding for interleukin 12.
Barajas M; Mazzolini G; Genové G; Bilbao R; Narvaiza I; Schmitz V; Sangro B; Melero I; Qian C; Prieto J
Hepatology; 2001 Jan; 33(1):52-61. PubMed ID: 11124820
[TBL] [Abstract][Full Text] [Related]
19. In vivo cancer gene therapy with a recombinant interleukin-2 adenovirus vector.
Toloza EM; Hunt K; Swisher S; McBride W; Lau R; Pang S; Rhoades K; Drake T; Belldegrun A; Glaspy J; Economou JS
Cancer Gene Ther; 1996; 3(1):11-7. PubMed ID: 8785705
[TBL] [Abstract][Full Text] [Related]
20. Regression of colon cancer and induction of antitumor immunity by intratumoral injection of adenovirus expressing interleukin-12.
Mazzolini G; Qian C; Xie X; Sun Y; Lasarte JJ; Drozdzik M; Prieto J
Cancer Gene Ther; 1999; 6(6):514-22. PubMed ID: 10608348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]